Id Biomedical Corporation Of Northborough is categorized under Vaccines in Northborough, MA and active since 2004.
Id Biomedical Corporation Of Northborough was established in 2004, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Vaccines business, which does work in the B2B market, and is classified as a Vaccines, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Anthony Holler at the company’s single location by writing to 30 Bearfoot Road, Northborough, Massachusetts MA 01532 or by phoning (508) 351-9944. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Id Biomedical Corporation Of Northborough |
Contact Person: | Anthony Holler |
Address: | 30 Bearfoot Road, Northborough, Massachusetts 01532 |
Phone Number: | (508) 351-9944 |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Vaccines |
SIC Code: | 2836 |
NAICS Code: | 325414 |
Share This Business: |
Id Biomedical Corporation Of Northborough was started in 2004 to provide professional Vaccines under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Anthony Holler for inquiries that concern Id Biomedical Corporation Of Northborough by calling the company number (508) 351-9944, as your correspondence is most welcome. Additionally, the physical location of the single location of Id Biomedical Corporation Of Northborough can be found at the coordinates 42.342098,-71.629507 as well as the street address 30 Bearfoot Road in Northborough, Massachusetts 01532.
For its online presence, you may visit Id Biomedical Corporation Of Northborough’s website at and engage with its social media outlets through on Twitter and on Facebook.